| Drugs (121) |  |
The most advanced methods of mass production employ harmful antibiotics and genetically modified feed in unnaturally crowded ponds on land.
Look for wait-less systems to spring to life in doctor offices, auto service shops, pharmacies, Disneyland,
Health professionals capable of working on the nano-level, both in designing diagnostics systems, remedies, and monitoring solutions will be in high demand. 23.
and dispense drugs. Such devices may eventually be able to measure the level of cholesterol or alcohol in your blood and flash up an appropriate warning.
and Drug Administration to identify the source of an outbreak of foodborne illness, trace its path
a psychiatrist and former British drug czar, has identified six compounds similar to benzodiazepines#a broad class of psychoactive drugs#that won t get you rip-roaring drunk
all you d have to do is pop a pill. 21. The Mind-reading Shopping cart In February,
Then you could knock it out with a stronger disinfectant. 27. A New Firefighter You need a lot of water to put out a sizable blaze,
Sleep Better Researchers at Merck have created a pill called suvorexant that essentially makes you a narcoleptic for a night.
Unlike existing sleep aids, the drug (which will likely be reviewed by the F. D. A. later this year) works by turning off wakefulness rather than by inducing sleep.
There s good reason to believe this pill brings on more R. E. M. sleep and better rest,#says Dr. Emmanuel Mignot of Stanford university.
and dispense drugs. Such devices may eventually be able to measure the level of cholesterol or alcohol in your blood and flash up an appropriate warning.
Gene therapy-Gene therapy is the use of DNA as a pharmaceutical agent to treat disease, with the most common form involving DNA that has been encoded with a functional fix to replace a mutated one.
Laboratory-grown artemisinin, a key antimalarial drug, went on sale in April with the potential to help stabilize supply issues.
an ancient herbal remedy found to be more than 90 percent effective at curing those infected with malaria.
pharmaceutical giant Sanofi, has manufactured 35 tons of artemisinin#roughly equivalent to 70 million courses of treatment.
The World health organization gave its stamp of approval to the drug in May, and the pills are being used widely.
Concerns about risks The early scientific breakthroughs by the Amyris founders paved the way for dozens of other companies to do similar work.
and never get tired. 8. Sunscreen Pills An effective sunscreen that can be administered orally has been sought after for some time now.
The biotech revolution that created drugs like EPO for anemia and interferon for multiple sclerosis and crops like Monsanto s Roundup Ready soybeans was based on relatively crude methods for inserting a gene from one organism into another.
and primitive algae has resulted in drug and biofuel companies such as Amyris and LS9. But figuring out how to make changes in the genomes of more complicated organisms has been tough.
which would be useful in making yogurt and perhaps in manufacturing drugs. But he was quick to realize something else:
That could be hugely useful in for instance, developing new drugs. Recently, there was a bit of an internet uproar
The book dispensaries at available 24/7 and operate like ATM machines with a swipe of a library card to dispense books.
Hyper-Individualized Medicine Professor Lee Cronin at the University of Glasgow believes we will soon be using 3d printers to replace traditional pharmaceuticals with hyper-individualized medicines that are printed specifically for the person at the time they ordered them.
Health professionals capable of working on the nano-level, both in designing diagnostics systems, remedies, and monitoring solutions will be in high demand. 111.
and Drug Administration approval in the United states not a given by any means but rogue clinics or scientists in less-regulated nations could make attempts he said.
and pharmacology as we learn more about our natural environment. Hopefully too we can develop better ways of reducing the huge amount of food loss that takes place
African innovation Africa is struggling to turn local discoveries into drugs and other health-care inventions
including several drug candidates and a dipstick test for schistosomiasis. Scientists have no incentive to commercialize results,
US pharmaceutical giant Johnson & johnson issued a long-awaited public offer to buy Crucell, a biotechnology firm headquartered in Leiden, The netherlands.
Business Orphan drugs European spending on research and development (R&d) of'orphan'drugs for rare diseases jumped from ¢ 158 million (US$207 million) in 2000 to nearly ¢Â
500 million in 2008 墉 doubling from 1%to 2. 2%of total European pharmaceutical R&d spending,
In that same period, global R&d spending on orphan drugs grew from ¢ 305 million to ¢ 1. 9 billion
The development of new countermeasures, from diagnostics to antibiotics and antivirals to respirators, will help protect human lives in the face of new bugs and superbugs.
His FDA has slowed the drug development process and inserted requirements that drive up the cost of developing new antibiotics.
A robust public health system is only as strong as the tools available, and I will empower the private sector to pursue the breakthroughs that will equip society for the health challenges of the twenty-first century.
The use of hormones, antibiotics and pesticides, as well as animal diseases and even terrorism pose risks. What steps would you take to ensure the health, safety and productivity of America s food supply?
I signed the most comprehensive reform of our nation s food safety laws in more than 70 years â oe giving the Food and Drug Administration the resources,
and minimize pesticides and antibiotics in our food. I set the ambitious goal to increase the number of certified organic operations by 20 percent â oe
And my administration is taking steps to limit antibiotic use for livestock. This will help ensure that antibiotics are used only address diseases and health problems
and not for enhancing growth and other production purposes. And I will continue to work on food safety issues to ensure that public health is the priority in our food safety system.
and food safety groups are concerned about contamination of food crops with products from a new generation of crops engineered to produce chemicals or pharmaceuticals.
there is no antidote, but symptoms can be treated. The suspect, Paul Kevin Curtis, of Corinth, faces up to 15 years in prison if convicted.
the resurgence of measles and antimicrobial resistance are discussed all at the European Society of Clinical Microbiology
I don't think massive amounts of intoxicating drugs would make Dan's writing any better.
Please up your dosage of Xanax. Now to the debunking. The earth can easily sustain the current population of 7. 1 billion.
My question to you is do you have antibiotics that kill resistant bacteria's and viruses?
i have nearly 50 different organic antibiotics and all i ever get is slag from online posters when
but since the elite control the governments of the world and big pharma this solution will most likely be governed by them.
Many of those other 600 studies were conducted by seed dispensaries. They sell the seeds so you can see why that would be beneficial to say they're safe.
Sincerely-Joehttp://www. joesid. comso TANGSTEN point us to a study not tainted by seed dispensary money that shows that GMO foods are measurably more dangerous than non-GMO foods.
Specific drugs that were found to cause harm and were banned subsequently did not trigger a blanket ban on ALL OF the same kind of medication.
For example while thalidomide was banned there was never a blanket ban on all anti-nausea medication. And the FDA never approved its use in the U s. at any time during the 5 years it was available.
It is possible that specific GMO foods in the future--ones not studied and certified yet--may turn out to be more harmful than their non-GMO counterparts.
Organovo's first biological product will be liver tissue for drug testing. Every year the pharmaceutical industry spends more than $39 billion on R&d.
According to the Food and Drug Administration liver toxicity is the most common reason for a drug to be pulled from clinical trials as well as from the marketplace after it's been approved.
There's still no reliable way to evaluate how a drug will affect the human liver before it's ingested not even animal trials.
A study published in October showed the mice predicted how well a drug for treating hepatitis C would be metabolized by humans.
Every drug taken orally whether a painkiller an anti-inflammatory or a new cancer pill must pass a liver tox.
People normally do a reaction purify the chemicals take the drug add it to cells look at the response formulate maybe do animals
and then go to humans says Lee Cronin a University of Glasgow chemist and nanoscientist developing a 3-D printer to manufacture medicine using chemical inks.
If bioprinted assays provide pharmaceutical researchers with better quicker data the entire drug-discovery process will accelerate.
The unconquerable Gorgas with a good force of physicians surgeons nurses expert sanitarians skilled engineers and helpers with ample supplies of disinfectants were put in the lead.
Disinfectants were used freely and fumigation resorted to when necessary in handling contagious diseases. Rotting vegetable and animal matter offal
good dispensaries were established in convenient places; a hospital car was run with every train for the ill or the injured;
#GUMBOS technology promises new drugs, electronic devicesmention a breakthrough involving gumbo technology in New orleans and people think of a new twist on The Local Dish the stew that's the quintessence of southern Louisiana cooking.
For example some nanoparticles are used as the drug delivery vehicle. We can make nanogumbos that are both the drug
and the drug delivery vehicle he said. Warner cited as one example a newly developed nanogumbos material with a provisional patent application filed that his team at LSU foresees as a lead in possible development of new anticancer drugs.
Using in vitro studies they are completing key research to better understand how nanogumbos can be tuned to be selectively toxic to cancer cells and nontoxic to normal cells.
More details are presented on this technology at this New orleans ACS meeting. We have a material that is normally toxic to both cancer cells
This presentation will consider the antibacterial mechanisms of various nanomaterials within the context of environmental implications and applications.
and will allow us to better understand the mechanism of drug resistance that is common in prostate cancer patients.
and maintain their integrity for sophisticated genomic and behavioral analyses said Hsian-Rong Tseng Phd associate professor of molecular and medical pharmacology at UCLA and the inventor of the Nanovelcro Chip concept and device.
#Lack of energy an enemy to antibiotic-resistant microbesrice University researchers cured a strain of bacteria of its ability to resist an antibiotic in an experiment that has implications for a longstanding public health crisis. Rice environmental engineer Pedro Alvarez
and his team managed to remove the ability of the Pseudomonas aeruginosa microorganism to resist the antibiotic medication tetracycline by limiting its access to food and oxygen.
and often transmissible DNA element--that allows it to resist tetracycline. The researchers'results reported this month in the American Chemical Society journal Environmental science
and Technology are the latest in a long effort to understand the environmental aspects of antibiotic resistance which threatens decades of progress in fighting disease.
The propagation of antibiotic resistance has been perceived as a medical or microbiology-related problem Alvarez said.
A lot of the antibiotic-resistant bacteria originate in animal agriculture where there is overuse misuse and abuse of antibiotics.
Alvarez contended that confined animal feeding operations (CAFOS) are potential sources of environmental contamination by antibiotics
and the associated antibiotic-resistant genes that find their way into the ground water and ultimately the food supply.
We started with the hypothesis that microbes don't like to carry excess baggage he said. That means they will drop genes they're not using
and/or oxygen through successive generations they found that in the absence of tetracycline both microbes dumped the resistance plasmid though not entirely in the case of E coli.
which made it susceptible once again to antibiotics. When a high level of tetracycline was present both microbes retained a level of resistance One long-recognized problem with antibiotics is that they tend to snatch defeat from the jaws of victory.
If any antibiotic-resistant bacteria are part of a biological mix whether in a person an animal or in the environment the weak microbes will die
and the resistant will survive and propagate; this process is known by biologists as selective pressure.
If we can put an anaerobic barrier at the point where a lagoon drains into the environment we will essentially exert selective pressure for the loss of antibiotic-resistant genes
His study of the Haihe River in China funded by the Chinese government and published last year found tetracycline resistance genes are common in the environment there as well.
and Drug Administration's seal of approval for containing omega-3 fatty acids. Todd Hansen CEO of NBO3 Technologies LLC said consumer response has been positive in test markets.
because there's a large potential payoff in terms of reducing costs for pharmaceutical and toxicological testing. Nano3d Biosciences won a Small Business Innovation Research (SBIR grant from the National Science Foundation (NSF) in 2011 to create a four-layered lung tissue from endothelial cells smooth muscle cells
and Drug Administration to begin studies in human patients. This is expected to take several years.
The milk extracted from the cow is also unsuitable for the food chain causing substantial loss due to treatment with antibiotics
and keep the corn cubs for food we have come a long way says Per Morgen professor at the Institute of Physics Chemistry and Pharmacy University of Southern Denmark.
and South africa thanks to a $400000 prize announced Nov 14 as part of the inaugural Healthcare Innovation Award program sponsored by pharmaceutical giant Glaxosmithkline and London-based nonprofit Save the Children.
and Drug Administration (FDA) and considered safe from a food safety perspective to improve the cattle's natural ability to convert feed into more lean muscle.
Second, the honey in question contained antibiotics that are regulated more closely in the United states. It turns out
Futurist Fixes 1. The Food Pill. In the future, we may see a type of pill for replacing food,
but experts say it likely would not be a simple compound of chemicals. A pill-sized food replacement system would have to be extremely complex because of the sheer difficulty of the task it was being asked to perform
more complex than any simple chemical reaction could be. The most viable solution, according to many futurists, would be a nanorobot food replacement system.
and senior research fellow at the Institute for Molecular Manufacturing, has described several potential food replacement technologies that are somewhat pill-like.
however, is that instead of containing drug compounds, the capsules would contain thousands of microscopic robots called nanorobots.
According to Hessel, individualized drugs could lower the cost of drug development across the entire spectrum of the development chain.
medical drugs and devices, over-the-counter medicine, clinical therapies, etc. This field has taken on a life of its own due to economic incentives:
genetically modified drugs (i e.,, oebiologics) at $75 billion; genetically modified seeds and crops at $110 billion;
livestock which produce medications or biological substances such as spider-silk; and an optimal source of biofuel.
The Guardian covered the conference by focusing on a recent lab achievement to produce the antimalarial drug, artemisinin
Along with that loss may come the loss of the plant diversity and a new, less desirable oemonotherapy drug.
Critics say the new drug production method is potentially damaging, entirely unnecessary, and causes harm by taking away the livelihood of poor farmers.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011